Rare
lephants
Screener
Toggle theme
10x Genomics, Inc.
TXG
·
Technology, Scientific & Technical Instruments, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2019
Total Cash from Operations:
$187.5M
Line Item
Value
% of Total
Capital Expenditures
$12.4M
6.6%
Other Investing
$5.2M
2.8%
Working Capital
$170.0M
90.6%
Net Cash Flow
$0
0.0%
Download CSV
